| abstract |
Compounds of formula (I) or pharmaceutically acceptable salts thereof, compositions, combinations and medicaments containing said compounds and methods for their preparation. The invention also relates to the use of said compounds, combinations, compositions and medicaments as estrogen receptor activity inhibitors, including estrogen receptor degradation, treatment of diseases and conditions mediated by estrogen receptor, for example. . [Chemical 1] [Selection figure] None |